ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,187.67
0.00%
US Tech 100
17,585.60
-0.15%
다우존스 지수
39,056.39
0.44%
Bitcoin
61,456.66
0.44%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NYSE
  6. Abbott Laboratories (ABT)

  7. Abbott Laboratories (ABT) 뉴스

ABT

Abbott Laboratories (ABT)

Abbott Laboratories
일자:
정렬 기준:
 검색 관련기사 보기:NYSE:ABT
일자시간출처헤드라인심볼기업
2024/05/0906:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
2024/05/0807:59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
2024/04/2922:00PR Newswire (US)Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the KneeNYSE:ABTAbbott Laboratories
2024/04/1800:37IH Market NewsAbbott Laboratories Reports Strong Q1 Sales Growth Amid Earnings Decline, Raises Full-Year GuidanceNYSE:ABTAbbott Laboratories
2024/04/1720:30PR Newswire (US)Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance RangesNYSE:ABTAbbott Laboratories
2024/04/1719:59IH Market NewsUS Index Futures See Gains, Oil Prices DipNYSE:ABTAbbott Laboratories
2024/04/0320:12IH Market NewsCal-Maine Surges on Strong Quarterly Performance, Taiwan Earthquake Disrupts Tech Supply Chain, and MoreNYSE:ABTAbbott Laboratories
2024/04/0222:00PR Newswire (US)Abbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart ValveNYSE:ABTAbbott Laboratories
2024/04/0122:00PR Newswire (US)Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's BedsideNYSE:ABTAbbott Laboratories
2024/03/2805:30PR Newswire (US)Abbott Hosts Conference Call for First-Quarter EarningsNYSE:ABTAbbott Laboratories
2024/03/1921:00PR Newswire (Canada)Canadian First - Abbott Advances Chronic Pain Management with the World's Smallest Implanted, Rechargeable Spinal Cord Stimulation SystemNYSE:ABTAbbott Laboratories
2024/03/1921:00PR Newswire (Canada)Une première au Canada -- Abbott fait progresser le traitement de la douleur chronique grâce au plus petit système de stimulation de la moelle épinière implantée et rechargeable au mondeNYSE:ABTAbbott Laboratories
2024/03/0623:00PR Newswire (US)Real-World Data Show Abbott's FreeStyle Libre® Systems and GLP-1 Medicines Work Better Together for People with Type 2 DiabetesNYSE:ABTAbbott Laboratories
2024/03/0509:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
2024/03/0509:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
2024/03/0509:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
2024/03/0509:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
2024/03/0509:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
2024/03/0509:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
2024/03/0508:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
2024/03/0508:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
2024/03/0508:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
2024/03/0508:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
2024/03/0207:53Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
2024/03/0207:45Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
2024/03/0207:39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
2024/03/0207:32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
2024/03/0207:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
2024/03/0207:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
2024/02/2808:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
 검색 관련기사 보기:NYSE:ABT

최근 히스토리

USOTC
BNPQY
BNP Paribas (QX)
COIN
ETHUSD
Ethereum
NASDAQ
TSLA
Tesla
CCOM
US500
US 500
NYSE
VZ
Verizon Communications
USOTC
BASFY
BASF (QX)
CCOM
SILVER
SILVER
NYSE
AXP
American Express
CCOM
US100
US Tech 100
NASDAQ
NVDA
NVIDIA
NYSE
XOM
Exxon Mobil
NASDAQ
MSFT
Microsoft
SPI
SP500
S&P 500
NYSE
JPM
JP Morgan Chase
NYSE
CVX
Chevron
FX
USDGBP
US Dollar vs Sterling
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유